Current Roles

Employees:
85
Revenue:
$21.3M
About
Check-Cap is advancing the development of C-Scanᅢツᅡᆴ, the first and only preparation-free ingestible scanning capsule for the prevention of colorectal cancer (CRC) through the detection of precancerous polyps. The patient-friendly test has the potential to increase screening adherence and reduce the overall incidence of CRC. The C-Scanᅢツᅡᆴ system is comprised of an x-ray scanning capsule that communicates with a tracking and recording unit as well as proprietary software to generate 3D maps of the inner lining of the colon for the detection of precancerous polyps and other lesions. Please view our notice here: http://www.check-cap.com/legal-notice
Check-Cap Ltd. Address
NA
Isfiya, null
Israel
Check-Cap Ltd. Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.